Altis Labs closes $25M Series A funding round
1 Sep 21 · 5d ago · 2 articles · 1 source · development 1 of 1
Toronto-based healthtech startup Altis Labs announced completion of a $25 million USD ($35 million CAD) Series A round co-led by biotech investor OrbiMed and Qiming Venture Partners USA. The funding will support expansion of the company's AI-powered prognosis platform for clinical trials.
“Altis Labs has closed a $25-million USD ($35-million CAD) Series A round to expand its AI-powered prognosis platform for clinical trials.”
BetaKit · techmeme ↗Altis Labs AI healthcare startupFelix Baldauf-Lenschen Altis Labs co-founder and CEOOrbiMed Series A co-lead investorQiming Venture Partners USA Series A co-lead investor
The whole story articles the bright band is this development · numbered dots are the others · click one to jump
What was reported 1 claim about this development
-
first by BetaKit, 5d ago
All 1 developments of Altis Labs raises $25M Series A for AI cancer trial analysis →
Newswires